Skip to main content
. Author manuscript; available in PMC: 2020 Dec 20.
Published in final edited form as: Clin Neurophysiol. 2018 Sep 6;129(11):2306–2314. doi: 10.1016/j.clinph.2018.08.022

Table 5.

Sleepiness in Subjects With Vs. Without PLMS Stratified by RLS Symptom Status

RLS Symptoms Positive PLMI <15 PLMI ≥15
Subjects/ Observations (368/829) 499 observations (n=234) 330 observations (n=134)

Characteristic mean ± SE mean ± SE p-value
MSLT mean (305/600) 11.4 ± 0.4 10.3 ± 0.4 p=0.0077
Epworth mean (367/828) 9.1 ± 0.4 9.8 ± 0.4 p=0.0030
Characteristic Odds Ratio (95% CI)
MSLT <8 (305/600) 1.87 (1.22-2.86)
Epworth >10 (367/828) 1.17 (0.88 - 1.54)
EDS 2.17 (1.47 - 3.12)

RLS Symptoms Negative PLMI <15 PLMI ≥15
Subjects/ Observations (513/1120) 818 observations (n=400) 302 observations (n=113)

Characteristic mean ± SE mean ± SE p-value
MSLT mean (398/765) 11.7 ± 0.4 12.2± 0.4 p=0.1604
Epworth mean (512/1119) 8.8 ± 0.3 8.9 ± 0.4 p=0.925
Characteristic Odds Ratio (95% CI)
MSLT <8 (398/765) 0.70 (0.50 - 1.10)
Epworth >10 (512/1119) 1.03 (0.77 - 1.39)
EDS 0.89 (0.59 - 1.34)

Reported mean ± standard error (SE) based on observations, not subjects. p-values based on F statistic.

Adjusted for age, gender, depression, habitual sleep time, insomnia, total sleep time, sleep efficiency, cardiovascular disease. PLMI, periodic limb movement index based Stanford’s PLM detector; RLS, restless legs syndrome symptoms (as described in Methods Section); MSLT, multiple sleep latency test; EDS, excessive daytime sleepiness (as described in Methods Section).